← Leaderboards
Derek A Pociask
University Of Pittsburgh At Pittsburgh
$2,330,869
Attributed
$2,330,869
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $602K · FY2015–25$1M$750K$500K$250K$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,330,869 · 3
By mechanism
R01$1,496,244 · 1
R21$834,625 · 2
Top collaborators
No co-investigators on record.
Most similar at University Of Pittsburgh At Pittsburgh
Same institution · by research overlap
- Cheryl L Fattman$2,636,913
- Fadi G. Lakkis$19,632,585
- Joel S Greenberger$22,565,586
- Kayhan Batmanghelich$3,514,366
- Lina Ghaloul-Gonzalez$910,360
Others in their field
Top investigators on “Viral”
- Lawrence Corey · Fred Hutchinson Cancer Center$466,994,927
- David Heimbrook · Leidos Biomedical Research, Inc.$366,090,791
- Daniel R Kuritzkes · Brigham And Women'S Hospital$267,074,199
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$252,763,614
- Judith S. Currier · University Of California Los Angeles$185,434,785
- Constance Ann Benson · University Of California, San Diego$165,517,633
Research focus
ViralPandemic DiseaseCellsDisease OutbreaksInfluenzaDesignInfectionMortalityInjuryInflammationInsightInflammatoryInfluenza A Virus, H1n1 SubtypeInfluenza A VirusFunctional DisorderEconomic BurdenHospitalizationCenters For Disease Control And Prevention (U.S.)Burden Of IllnessAdult Respiratory Distress SyndromeCoupledEpithelialCessation Of LifeChild
Grant awards (8)
Recent thyme emigrants mitigate viral pulmonary pneumonia$191,250
R21 · FY2025 · AI · contact PI
Recent thyme emigrants mitigate viral pulmonary pneumonia$229,500
R21 · FY2024 · AI · contact PI
IL-22: A therapeutic cytokine for the amelioration of pulmonary influenza injury$367,497
R01 · FY2018 · HL · contact PI
IL-22: A therapeutic cytokine for the amelioration of pulmonary influenza injury$367,497
R01 · FY2017 · HL · contact PI
The IL-22/IL-22 binding protein axis is critical for viral induced thymic atrophy and regeneration$188,125
R21 · FY2017 · AI · contact PI
IL-22: A therapeutic cytokine for the amelioration of pulmonary influenza injury$376,250
R01 · FY2016 · HL · contact PI
The IL-22/IL-22 binding protein axis is critical for viral induced thymic atrophy and regeneration$225,750
R21 · FY2016 · AI · contact PI
IL-22: A therapeutic cytokine for the amelioration of pulmonary influenza injury$385,000
R01 · FY2015 · HL · contact PI